These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 32784383)

  • 1. Role of Inflammasomes in HIV-1 and Drug Abuse Mediated Neuroinflammaging.
    Sil S; Niu F; Chivero ET; Singh S; Periyasamy P; Buch S
    Cells; 2020 Aug; 9(8):. PubMed ID: 32784383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Autophagy in HIV-1 and Drug Abuse-Mediated Neuroinflammaging.
    Sil S; Thangaraj A; Oladapo A; Hu G; Kutchy NA; Liao K; Buch S; Periyasamy P
    Viruses; 2022 Dec; 15(1):. PubMed ID: 36680084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The far-reaching HAND of cART: cART effects on astrocytes.
    Gonzalez H; Podany A; Al-Harthi L; Wallace J
    J Neuroimmune Pharmacol; 2021 Mar; 16(1):144-158. PubMed ID: 32147775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroinflammation & pre-mature aging in the context of chronic HIV infection and drug abuse: Role of dysregulated autophagy.
    Guo ML; Buch S
    Brain Res; 2019 Dec; 1724():146446. PubMed ID: 31521638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the immune system in HIV-associated neuroinflammation and neurocognitive implications.
    Hong S; Banks WA
    Brain Behav Immun; 2015 Mar; 45():1-12. PubMed ID: 25449672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the inflammasomes in HIV-associated neuroinflammation and neurocognitive disorders.
    Katuri A; Bryant J; Heredia A; Makar TK
    Exp Mol Pathol; 2019 Jun; 108():64-72. PubMed ID: 30922769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of substance abuse on HIV-mediated neuropathogenesis in the current ART era.
    Chilunda V; Calderon TM; Martinez-Aguado P; Berman JW
    Brain Res; 2019 Dec; 1724():146426. PubMed ID: 31473221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial and Adverse Effects of cART Affect Neurocognitive Function in HIV-1 Infection: Balancing Viral Suppression against Neuronal Stress and Injury.
    Yuan NY; Kaul M
    J Neuroimmune Pharmacol; 2021 Mar; 16(1):90-112. PubMed ID: 31385157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Dysregulated Autophagy in HIV Tat, Cocaine, and cART Mediated NLRP3 Activation in Microglia.
    Singh S; Thangaraj A; Chivero ET; Guo ML; Periyasamy P; Buch S
    J Neuroimmune Pharmacol; 2023 Sep; 18(3):327-347. PubMed ID: 37148425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aging, comorbidities, and the importance of finding biomarkers for HIV-associated neurocognitive disorders.
    Rosenthal J; Tyor W
    J Neurovirol; 2019 Oct; 25(5):673-685. PubMed ID: 30868422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-Associated Neurocognitive Disorder: A Look into Cellular and Molecular Pathology.
    Thompson LJ; Genovese J; Hong Z; Singh MV; Singh VB
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV Neuropathogenesis in the Presence of a Disrupted Dopamine System.
    Nickoloff-Bybel EA; Calderon TM; Gaskill PJ; Berman JW
    J Neuroimmune Pharmacol; 2020 Dec; 15(4):729-742. PubMed ID: 32506353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current understanding of HIV-associated neurocognitive disorders pathogenesis.
    Gannon P; Khan MZ; Kolson DL
    Curr Opin Neurol; 2011 Jun; 24(3):275-83. PubMed ID: 21467932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does HIV infection contribute to increased beta-amyloid synthesis and plaque formation leading to neurodegeneration and Alzheimer's disease?
    Fulop T; Witkowski JM; Larbi A; Khalil A; Herbein G; Frost EH
    J Neurovirol; 2019 Oct; 25(5):634-647. PubMed ID: 30868421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Important role of microglia in HIV-1 associated neurocognitive disorders and the molecular pathways implicated in its pathogenesis.
    Borrajo A; Spuch C; Penedo MA; Olivares JM; Agís-Balboa RC
    Ann Med; 2021 Dec; 53(1):43-69. PubMed ID: 32841065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Challenges of HIV-1 Infection: How HIV-1 Attacks and Resides in the Central Nervous System.
    Rojas-Celis V; Valiente-Echeverría F; Soto-Rifo R; Toro-Ascuy D
    Cells; 2019 Oct; 8(10):. PubMed ID: 31614895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of neuronal dysfunction in HIV-associated neurocognitive disorders.
    Irollo E; Luchetta J; Ho C; Nash B; Meucci O
    Cell Mol Life Sci; 2021 May; 78(9):4283-4303. PubMed ID: 33585975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proceedings of the 2017 ISEV symposium on "HIV, NeuroHIV, drug abuse, & EVs".
    Hu G; Yelamanchili S; Kashanchi F; Haughey N; Bond VC; Witwer KW; Pulliam L; Buch S
    J Neurovirol; 2017 Dec; 23(6):935-940. PubMed ID: 29147885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurologic disease in HIV-infected children and the impact of combination antiretroviral therapy.
    Crowell CS; Malee KM; Yogev R; Muller WJ
    Rev Med Virol; 2014 Sep; 24(5):316-31. PubMed ID: 24806816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic inflammation and the role for cofactors (hepatitis C, drug abuse, antiretroviral drug toxicity, aging) in HAND persistence.
    Gill AJ; Kolson DL
    Curr HIV/AIDS Rep; 2014 Sep; 11(3):325-35. PubMed ID: 24929842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.